SpyGlass Pharma, Inc.

SpyGlass Pharma, Inc. financial statements

SpyGlass Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 39.87M10-K
Cash and equivalentsUSD 96.36M10-Q
Total debtUSD 1.58MEODHD

SpyGlass Pharma, Inc. financials on 6ix · SpyGlass Pharma, Inc. on 6ix